Pringle, Toni A.
Ramon-Gil, Erik
Leslie, Jack
Oakley, Fiona
Wright, Matthew C.
Knight, James C.
Luli, Saimir
Funding for this research was provided by:
Medical Research Council (MR/K0019494/1, MR/R023026/1)
Wellcome Trust Institutional Strategic Support Fund
Article History
Received: 16 May 2023
Accepted: 25 December 2023
First Online: 5 January 2024
Competing interests
: Wright MC has a financial interest in any commercial exploitation of the C1–3 antibody through any licensing agreement of a previous employer but takes no part and has no influence on any commercialisation activities. All other authors declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.